Bionano Genomics Stock Price on October 19, 2021
| BNGO Stock | USD 0.76 0.01 1.33% |
Below is the normalized historical share price chart for Bionano Genomics extending back to September 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bionano Genomics stands at 0.76, as last reported on the 23rd of April, with the highest price reaching 0.79 and the lowest price hitting 0.74 during the day.
If you're considering investing in Bionano Stock, it is important to understand the factors that can impact its price. Bionano Genomics secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19% return per unit of risk over the last 3 months. Bionano Genomics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bionano Genomics' Risk Adjusted Performance of (0.1), standard deviation of 3.83, and Mean Deviation of 2.93 to double-check the risk estimate we provide.
At this time, Bionano Genomics' Common Stock Total Equity is very stable compared to the past year. As of the 23rd of April 2024, Common Stock Shares Outstanding is likely to grow to about 35.9 M, while Total Stockholder Equity is likely to drop about 89.9 M. . As of the 23rd of April 2024, Price To Sales Ratio is likely to drop to 1.70. In addition to that, Price Earnings Ratio is likely to drop to -0.29. Bionano Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of August 2018 | 200 Day MA 2.3125 | 50 Day MA 1.0916 | Beta 2.372 |
Bionano |
Sharpe Ratio = -0.1886
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BNGO |
Estimated Market Risk
| 3.79 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.72 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bionano Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionano Genomics by adding Bionano Genomics to a well-diversified portfolio.
Price Book 0.6225 | Enterprise Value Ebitda (0.18) | Price Sales 1.6572 | Shares Float 54.5 M | Wall Street Target Price 6.67 |
Bionano Genomics Valuation on October 19, 2021
It is possible to determine the worth of Bionano Genomics on a given historical date. On October 19, 2021 Bionano was worth 2.37 at the beginning of the trading date compared to the closed value of 23.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bionano Genomics stock. Still, in general, we apply an absolute valuation method to find Bionano Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bionano Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bionano Genomics' related companies.
| Open | High | Low | Close | Volume | |
04/07/2022 | 2.37 | 23.20 | 23.20 | 23.20 | 714,279 |
| 2.32 | 22.00 | 22.00 | 22.00 | 554,960 |
| Backtest Bionano Genomics | | | Bionano Genomics History | | | Bionano Genomics Valuation | Next |
Bionano Genomics Trading Date Momentum on October 19, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Bionano Genomics Fundamentals Correlations and Trends
By evaluating Bionano Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bionano Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bionano financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bionano Genomics Stock history
Bionano Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bionano is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bionano Genomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bionano Genomics stock prices may prove useful in developing a viable investing in Bionano Genomics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 34.1 M | 35.9 M | |
| Net Loss | -119.3 M | -113.4 M |
Bionano Genomics Stock Technical Analysis
Bionano Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bionano Genomics Period Price Range
Low | April 7, 2022
| High |
2.37 | 23.20 |
Bionano Genomics April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Bionano Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionano Genomics shares will generate the highest return on investment. By undertsting and applying Bionano Genomics stock market strength indicators, traders can identify Bionano Genomics entry and exit signals to maximize returns
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 9.79 | |||
| Day Median Price | 23.2 | |||
| Day Typical Price | 23.2 | |||
| Price Action Indicator | 10.42 | |||
| Period Momentum Indicator | (22.44) |
Bionano Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bionano Genomics' price direction in advance. Along with the technical and fundamental analysis of Bionano Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bionano to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.16) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.Note that the Bionano Genomics information on this page should be used as a complementary analysis to other Bionano Genomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Bionano Stock analysis
When running Bionano Genomics' price analysis, check to measure Bionano Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionano Genomics is operating at the current time. Most of Bionano Genomics' value examination focuses on studying past and present price action to predict the probability of Bionano Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionano Genomics' price. Additionally, you may evaluate how the addition of Bionano Genomics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Bionano Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.81) | Revenue Per Share 1.058 | Quarterly Revenue Growth 0.305 | Return On Assets (0.33) | Return On Equity (1.35) |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.